DR. SARA MICHEL Select Publications and Abstracts Grund, Dr. Martin, Michel, Dr. Sara and Farmer, Dr. Stacey J. (2010) "European Court of Justice to Decide the Fate of Patenting Stem Cells in Europe", Bio-Science Law Review, Vol. 10, Issue 5, pp. 193-197. Halama N, Zoernig I, Spille A, Michel S, Kloor M, Grauling-Halama S, Westphal K, Schirmacher P, Jäger D, Grabe N. Quantification of prognostic immune cell markers in colorectal cancer using whole slide imaging tumor maps. Anal Quant Cytol Histol, 32:333-340 (2010). Bergmann F, Singh S, Michel S, Kahlert C, Schirmacher P, Helmke B, Von Knebel Doeberitz M, Kloor M, Bläker H. Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway. Oncol Rep, 24:1535-1539 (2010). Kloor M, Michel S, von Knebel Doeberitz M. Immune evasion of microsatellite unstable colorectal cancers. Int J Cancer, 127:1001-1010 (2010). Michel S, Linnebacher M, Alcaniz J, Voss M, Wagner R, Dippold W, Becker C, von Knebel Doeberitz M, Ferrone S, Kloor M. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int. J. Cancer PMID: 20013806 (2010). Michel S, Kloor M, Singh S, Gdynia G, Roth W, von Knebel Doeberitz M, Schirmacher P, Bläker H. Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Molec. Carcin. PMID: 19852062 (2009) (first two authors contributed equally). Halama N, Michel S, Kloor M, Zoernig I, Pommerencke T, von Knebel Doeberitz M, Schirmacher P, Weitz J, Grabe N, Jäger D. The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy. Cancer Immunol., 9:1-6 (2009) (first two authors contributed equally). Kloor M, Michel S, von Knebel Doeberitz M. Molekulare Pathogenese. Ihre Bedeutung für die zielgerichtete Therapie beim kolorektalen Karzinom. Pathologe, 29:196-199 (2008). Michel S, Benner A, Tariverdian M, Wentzensen N, Hoefler P, Pommerencke T, Grabe N, von Knebel Doeberitz M, Kloor M. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br. J. Cancer, 99:1867-1873 (2008). Kloor M, Michel S, Buckowitz B, Rüschoff J, Büttner R, Holinski-Feder E, Dippold W, Wagner R, Tariverdian M, Benner A, Schwitalle Y, Kuchenbuch B, von Knebel Doeberitz M. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors. Int. J. Cancer, 121:454-458 (2007) (first two authors contributed equally). Select Speaking Engagements “Molecular mechanisms underlying the differential expression of HLA class II antigens in microsatellite unstable colorectal carcinoma.” 3rd Biennial Scientific Meeting of the International Society for Gastrointestinal Hereditary Tumours (InSIGHT), Düsseldorf, Germany (2009). Presentation at the American Association for Cancer Research (AACR) Annual Meeting, San Diego (2008). “Beta2-Microglobulin mutations in microsatellite unstable colorectal cancer: Association with stage and hereditary background.” 2nd Biennial Scientific Meeting of the International Society for Gastrointestinal Hereditary Tumours (InSIGHT), Yokohama, Japan (2007). |
| Grund IP Group ● Nikolaistrasse 15, D-80802, Munich, GERMANY ● FON: + 49 (89) 54 80 19-0 ● FAX: + 49 (89) 54 80 19-10 |
